{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:28:20Z","timestamp":1786980500689,"version":"build-2736575974"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10072-026-09106-0","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:28:13Z","timestamp":1779409693000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Anti-acetylcholine receptor antibody overshoot following efgartigimod in myasthenia gravis: Two case reports with literature review"],"prefix":"10.1007","volume":"47","author":[{"given":"Rui-Yuan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bian-Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jia","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Kai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Hua","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Dong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0536-1131","authenticated-orcid":false,"given":"Jian-Quan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"issue":"12","key":"9106_CR1","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1007\/s10072-024-07577-7","volume":"45","author":"R Mantegazza","year":"2024","unstructured":"Mantegazza R, Sacc\u00e0 F, Antonini G et al (2024) Therapeutic challenges and unmet needs in the management of myasthenia gravis: an Italian expert opinion. Neurol Sci 45(12):5671\u20135683. https:\/\/doi.org\/10.1007\/s10072-024-07577-7","journal-title":"Neurol Sci"},{"key":"9106_CR2","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3389\/fimmu.2020.00776","volume":"11","author":"ML Fichtner","year":"2020","unstructured":"Fichtner ML, Jiang R, Bourke A et al (2020) Autoimmune Pathology in Myasthenia Gravis Disease Subtypes Is Governed by Divergent Mechanisms of Immunopathology. Front Immunol 11:776. https:\/\/doi.org\/10.3389\/fimmu.2020.00776","journal-title":"Front Immunol"},{"issue":"7","key":"9106_CR3","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1007\/s10072-025-08096-9","volume":"46","author":"C Antozzi","year":"2025","unstructured":"Antozzi C, Frangiamore R, Rinaldi E et al (2025) Efgartigimod improves non-AChR generalized Myasthenia Gravis: a real world experience. Neurol Sci 46(7):3271\u20133279. https:\/\/doi.org\/10.1007\/s10072-025-08096-9","journal-title":"Neurol Sci"},{"key":"9106_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000385919","volume":"13","author":"TA Waldmann","year":"1969","unstructured":"Waldmann TA, Strober W (1969) Metabolism of immunoglobulins. Prog Allergy 13:1\u2013110. https:\/\/doi.org\/10.1159\/000385919","journal-title":"Prog Allergy"},{"issue":"3","key":"9106_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2450\/2007.0032-07","volume":"5","author":"R Reverberi","year":"2007","unstructured":"Reverberi R, Reverberi L (2007) Removal kinetics of therapeutic apheresis. Blood Transfus 5(3):164\u2013174. https:\/\/doi.org\/10.2450\/2007.0032-07","journal-title":"Blood Transfus"},{"issue":"12","key":"9106_CR6","doi-asserted-by":"publisher","first-page":"e50692","DOI":"10.7759\/cureus.50692","volume":"15","author":"K Kawama","year":"2023","unstructured":"Kawama K, Warabi Y, Bokuda K et al (2023) Exacerbation of Thymoma-Associated Myasthenia Gravis Following Efgartigimod Treatment Related to Anti-acetylcholine Receptor Antibody Overshoot: A Report of Two Cases. Cureus 15(12):e50692. https:\/\/doi.org\/10.7759\/cureus.50692","journal-title":"Cureus"},{"issue":"6","key":"9106_CR7","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/mus.880030603","volume":"3","author":"PC Dau","year":"1980","unstructured":"Dau PC (1980) Plasmapheresis therapy in myasthenia gravis. Muscle Nerve 3(6):468\u2013482. https:\/\/doi.org\/10.1002\/mus.880030603","journal-title":"Muscle Nerve"},{"issue":"4","key":"9106_CR8","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/jca.2920100410","volume":"10","author":"PC Dau","year":"1995","unstructured":"Dau PC (1995) Immunologic rebound. J Clin Apher 10(4):210\u2013217. https:\/\/doi.org\/10.1002\/jca.2920100410","journal-title":"J Clin Apher"},{"issue":"4","key":"9106_CR9","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/mus.27341","volume":"64","author":"J Ching","year":"2021","unstructured":"Ching J, Richards D, Lewis RA et al (2021) Myasthenia gravis exacerbation in association with antibody overshoot following plasmapheresis. Muscle Nerve 64(4):483\u2013487. https:\/\/doi.org\/10.1002\/mus.27341","journal-title":"Muscle Nerve"},{"issue":"4","key":"9106_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","volume":"87","author":"DB Sanders","year":"2016","unstructured":"Sanders DB, Wolfe GI, Benatar M et al (2016) International consensus guidance for management of myasthenia gravis: Executive summary. Neurology 87(4):419\u2013425. https:\/\/doi.org\/10.1212\/WNL.0000000000002790","journal-title":"Neurology"},{"issue":"1","key":"9106_CR11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/ene.15565","volume":"30","author":"A Meisel","year":"2023","unstructured":"Meisel A, Baggi F, Behin A et al (2023) Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal. Eur J Neurol 30(1):266\u2013282. https:\/\/doi.org\/10.1111\/ene.15565","journal-title":"Eur J Neurol"},{"issue":"5","key":"9106_CR12","doi-asserted-by":"publisher","first-page":"e200436","DOI":"10.1212\/NXI.0000000000200436","volume":"12","author":"F Khani-Habibabadi","year":"2025","unstructured":"Khani-Habibabadi F, Roy B, Pham MC et al (2025) AChR Autoantibody Pathogenic Properties Are Heterogeneously Distributed and Undergo Temporal Changes Among Patients With Myasthenia Gravis. Neurol Neuroimmunol Neuroinflamm 12(5):e200436. https:\/\/doi.org\/10.1212\/NXI.0000000000200436","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"9","key":"9106_CR13","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1136\/jnnp-2020-325511","volume":"92","author":"Y Kojima","year":"2021","unstructured":"Kojima Y, Uzawa A, Ozawa Y et al (2021) Rate of change in acetylcholine receptor antibody levels predicts myasthenia gravis outcome. J Neurol Neurosurg Psychiatry 92(9):963\u2013968. https:\/\/doi.org\/10.1136\/jnnp-2020-325511","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"9106_CR14","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1080\/08916934.2016.1214823","volume":"49","author":"JT Guptill","year":"2016","unstructured":"Guptill JT, Juel VC, Massey JM et al (2016) Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis. Autoimmunity 49(7):472\u2013479. https:\/\/doi.org\/10.1080\/08916934.2016.1214823","journal-title":"Autoimmunity"},{"issue":"4","key":"9106_CR15","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/trf.12923","volume":"55","author":"C Yamada","year":"2015","unstructured":"Yamada C, Ramon DS, Cascalho M et al (2015) Efficacy of plasmapheresis on donor-specific antibody reduction by HLA specificity in post-kidney transplant recipients. Transfusion 55(4):727\u2013735. https:\/\/doi.org\/10.1111\/trf.12923","journal-title":"Transfusion"},{"issue":"1","key":"9106_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/BF02043967","volume":"5","author":"M Valbonesi","year":"1984","unstructured":"Valbonesi M, Montani F, Florio G et al (1984) Plasmapheresis combined with lymphocytapheresis and cytotoxic drugs as a therapeutic modality in neuroimmunological diseases. Ital J Neurol Sci 5(1):35\u201340. https:\/\/doi.org\/10.1007\/BF02043967","journal-title":"Ital J Neurol Sci"},{"key":"9106_CR17","doi-asserted-by":"publisher","first-page":"102895","DOI":"10.1016\/j.jaut.2022.102895","volume":"132","author":"K Chen","year":"2022","unstructured":"Chen K, Li Y, Yang H et al (2022) Poor responses and adverse outcomes of myasthenia gravis after thymectomy: Predicting factors and immunological implications. J Autoimmun 132:102895. https:\/\/doi.org\/10.1016\/j.jaut.2022.102895","journal-title":"J Autoimmun"},{"key":"9106_CR18","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3389\/fimmu.2015.00395","volume":"6","author":"\u00cd Caramalho","year":"2015","unstructured":"Caramalho \u00cd, Nunes-Caba\u00e7o H, Foxall RB et al (2015) Regulatory T-Cell Development in the Human Thymus. Front Immunol 6:395. https:\/\/doi.org\/10.3389\/fimmu.2015.00395","journal-title":"Front Immunol"},{"issue":"1","key":"9106_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/rheumatology\/key236","volume":"58","author":"CC Chang","year":"2019","unstructured":"Chang CC, Lin TM, Chang YS et al (2019) Thymectomy in patients with myasthenia gravis increases the risk of autoimmune rheumatic diseases: a nationwide cohort study. Rheumatology (Oxford) 58(1):135\u2013143. https:\/\/doi.org\/10.1093\/rheumatology\/key236","journal-title":"Rheumatology (Oxford)"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09106-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09106-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09106-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T07:05:35Z","timestamp":1780988735000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-09106-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["9106"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09106-0","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"16 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by Ethics Committee of Nanjing First Hospital in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. Written informed consent was obtained from the the participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that there is no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"512"}}